Psychedelics & Neurostimulation for Brain Rewiring | Dr. Nolan Williams
Huberman Lab Podcast Recap
Published:
Duration: 3 hr 25 min
Guests: Dr. Nolan Williams
Summary
Dr. Nolan Williams discusses the use of transcranial magnetic stimulation (TMS) and psychedelics in treating depression and mood disorders. He explores how these methods can rewire brain circuits to alleviate symptoms, offering new hope for psychiatric treatment.
What Happened
Dr. Nolan Williams, a psychiatrist and neuroscientist at Stanford University, specializes in using transcranial magnetic stimulation (TMS) to treat depression and mood disorders. TMS works by activating or quieting specific brain circuits, targeting the dorsolateral prefrontal cortex to regulate mood and heart rate.
The episode delves into the use of psychedelics like psilocybin, MDMA, and ketamine for mood disorders. These substances are being studied for their potential to modify brain circuits without the hallucinogenic effects, focusing instead on their antidepressant properties.
Dr. Williams describes how ketamine's antidepressant effects may not be due to its dissociative properties. Instead, research is exploring the role of the opioid system and other mechanisms in mood regulation.
The brain's connectome is crucial in understanding depression and mania, with TMS affecting connectivity between the anterior cingulate and other brain regions. This method helps correct the timing of activation between the dorsolateral prefrontal cortex and the anterior cingulate, which is often reversed in depression.
Psychedelics like psilocybin have shown promise in altering brain connectivity, particularly between the subgenual anterior cingulate and the default mode network. This change can help patients perceive problems differently and alleviate persistent negative emotions.
Cannabis and its components, THC and CBD, have varying effects on psychosis and epilepsy. While high-potency THC can exacerbate psychosis, CBD has antipsychotic and antiepileptic properties, offering therapeutic potential.
The episode highlights the SAINT study, which uses TMS with a new protocol to treat depression more efficiently. This technique involves spaced learning theory, allowing for rapid and lasting remission of mood disorders in many patients.
Key Insights
- Transcranial Magnetic Stimulation (TMS) targets the dorsolateral prefrontal cortex to regulate mood and heart rate, offering rapid relief for depression within 1-5 days.
- Research into psychedelics aims to separate their antidepressant effects from hallucinogenic properties, with substances like psilocybin and MDMA showing potential for treating mood disorders.
- Ketamine's antidepressant effects may involve the opioid system, suggesting its benefits are not solely due to dissociation. Blocking opioid receptors can negate these effects.
- Cannabis contains THC and CBD, which have opposing effects on psychosis and epilepsy. High doses of THC can exacerbate psychosis, while CBD offers antipsychotic benefits.